Dhanuka Agritech Resultados de beneficios anteriores
Pasado controles de criterios 2/6
Dhanuka Agritech ha aumentado sus beneficios a una tasa media anual de 8.2%, mientras que los beneficios de la industria de Chemicals han experimentado un crecimiento de 6.5% anual. Los ingresos han ido creciendo a una tasa media de 8.7% al año. La rentabilidad financiera de Dhanuka Agritech es de 17.1%, y sus márgenes netos son de 14.2%.
Información clave
8.23%
Tasa de crecimiento de los beneficios
9.16%
Tasa de crecimiento del BPA
| Crecimiento de la industria Chemicals | 17.68% |
| Tasa de crecimiento de los ingresos | 8.72% |
| Rentabilidad financiera | 17.08% |
| Margen neto | 14.22% |
| Última actualización de beneficios | 31 Mar 2026 |
Actualizaciones de resultados anteriores recientes
Recent updates
Actualización de narrativa • Jun 15
507717: Share Buyback And Overseas Expansion Will Support Future Upside Potential
Analysts have kept their price target for Dhanuka Agritech broadly steady at around ₹1,414 per share. This reflects only marginal tweaks to assumptions on discount rate, long term revenue growth, profit margin and future P/E, rather than any change in their core view on the company.Actualización de narrativa • Jun 01
507717: Share Buyback Will Support Future Upside Confidence
Analysts have slightly reduced their price target on Dhanuka Agritech, with fair value moving from about ₹1,439.57 to ₹1,414.38 as they update assumptions around revenue growth, profit margins and forward P/E multiples. What's in the News The board will meet on May 19, 2026, to consider audited financial results for the quarter and financial year ended March 31, 2026; introduce and consider Employee Stock Option Scheme 2026, Employee Stock Appreciation Rights 2026, and Restricted Stock Unit Plan 2026; and address other matters.Actualización de narrativa • May 03
507717: Upcoming Director Appointment Will Support Future Upside Confidence
Analysts have nudged their price target on Dhanuka Agritech slightly higher, with fair value moving from ₹1,426.00 to about ₹1,439.57, citing updated assumptions around the discount rate, revenue growth, profit margins and future P/E. What's in the News A postal ballot based Special or Extraordinary Shareholders Meeting is scheduled for March 19, 2026, in India (Key Developments).Actualización de narrativa • Apr 18
507717: Upcoming Governance And Earnings Dates Will Support Future Upside Confidence
Analysts have trimmed their price target on Dhanuka Agritech slightly from ₹1,438.50 to ₹1,426.00, reflecting updated assumptions around the discount rate, revenue growth, profit margin, and forward P/E. What's in the News Special or Extraordinary Shareholders Meeting scheduled via postal ballot in India on Mar 19, 2026, to consider appointing Mr. Sanjiv Goel (DIN: 03616090) as an Independent Director for a first term of 5 years (company filing).Actualización de narrativa • Apr 03
507717: Upcoming Governance And Earnings Dates Will Support Upside Confidence
Analysts have kept their price target for Dhanuka Agritech steady at around ₹1,438, reflecting largely unchanged views on fair value, discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Dhanuka Agritech has scheduled a Special or Extraordinary Shareholders Meeting via postal ballot in India on March 19, 2026, to consider appointing Mr. Sanjiv Goel (DIN: 03616090) as an Independent Director for a first term of 5 years (Key Developments).Actualización de narrativa • Mar 19
507717: Upcoming Meetings Will Reinforce Confidence In Sustained Upside Potential
Analysts have kept the price target for Dhanuka Agritech broadly steady at around ₹1,438, with only minor model tweaks to the discount rate and the assumed future P/E driving the small change. What's in the News A Special or Extraordinary shareholders meeting is scheduled via postal ballot in India on Mar 19, 2026, to consider appointing Mr. Sanjiv Goel (DIN: 03616090) as an independent director for a first term of 5 years (company filing).Actualización de narrativa • Mar 05
507717: Upcoming Meetings Will Support Confidence In Long-Term Upside Potential
Analysts have maintained their ₹1,438.50 price target for Dhanuka Agritech and made only minor adjustments to their assumptions on discount rate, revenue growth, profit margin and future P/E. These limited changes suggest that their overall valuation framework remains broadly consistent with earlier assessments.
Nueva narrativa • Feb 21
Rural Distribution And Biostimulant Tailwinds Will Support A Stronger Long Term Outlook
Catalysts About Dhanuka Agritech Dhanuka Agritech is an Indian agrochemical company supplying crop protection and allied products to farmers across major agricultural regions in India. What are the underlying business or industry changes driving this perspective?Actualización de narrativa • Feb 19
507717: Upcoming Board And Shareholder Meetings Will Support Long-Term Upside Potential
Analysts have revised their price target on Dhanuka Agritech from ₹1,571.75 to ₹1,438.50, reflecting updated assumptions around the discount rate, expected revenue growth, profit margin and future P/E multiples. What's in the News Dhanuka Agritech has scheduled a Board Meeting on Feb 05, 2026, at 13:00 Indian Standard Time to consider and approve the financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).
Nueva narrativa • Feb 06
Dahej Ramp Up Risks And Regulatory Setbacks Will Eventually Support A Stronger Business
Catalysts About Dhanuka Agritech Dhanuka Agritech is an Indian agrochemical company supplying crop protection products and related offerings to farmers across major agricultural regions. What are the underlying business or industry changes driving this perspective?Actualización de narrativa • Feb 04
507717: Stable Assumptions And Upcoming Results Will Support Long-Term Upside Potential
Analysts have kept their price target for Dhanuka Agritech unchanged at ₹1,571.75, citing broadly consistent assumptions for the discount rate, revenue growth, profit margin and future P/E in their refreshed model. What's in the News Dhanuka Agritech has scheduled a board meeting on Feb 05, 2026.Actualización de narrativa • Jan 21
507717: Higher Margin Outlook Will Support Long-Term Upside Potential
Analysts have trimmed their price target for Dhanuka Agritech by ₹35 to ₹1,571.75. This reflects updated views on slightly lower revenue growth assumptions, a modestly higher discount rate, and a small adjustment to future P/E expectations, partly offset by a marginally higher profit margin outlook.Actualización de narrativa • Jan 06
507717: Nagpur Plant Land Purchase Will Support Long-Term Upside Potential
Analysts have kept their price target for Dhanuka Agritech unchanged at ₹1,606.75, with only minor tweaks to inputs such as the discount rate, revenue growth, profit margin, and future P/E assumptions guiding their view. What's in the News Board meeting scheduled on Oct 31, 2025 at 11:00 Indian Standard Time to review and approve financial results for the quarter and half year ended Sep 30, 2025 (company filing).Actualización de narrativa • Dec 16
507717: Nagpur Formulation Plant Expansion Will Drive Long-Term Upside Potential
Analysts have nudged their fair value estimate for Dhanuka Agritech down slightly from ₹1,638 to about ₹1,607 per share, reflecting tempered revenue growth expectations, partially offset by a modestly higher projected profit margin and a slightly lower assumed future P E multiple. What's in the News Board meeting scheduled on October 31, 2025, at 11:00 IST to review financial results for the quarter and half year ended September 30, 2025 (company filing) Board to consider purchase of land in Nagpur, Maharashtra, for setting up a new formulation plant, indicating planned capacity expansion (company filing) Outcome of the October 31, 2025 board meeting expected to provide clarity on near term growth, capex, and margin trajectory (company filing) Valuation Changes The fair value estimate was reduced slightly from ₹1,638 to about ₹1,607 per share, reflecting marginally softer assumptions.Actualización de narrativa • Dec 02
507717: Upcoming Nagpur Plant And Board Actions Will Fuel Long-Term Momentum
Analysts have maintained their fair value estimate for Dhanuka Agritech at ₹1,638, citing stable projections for growth and profitability despite minor adjustments in underlying assumptions. What's in the News Dhanuka Agritech will hold a Board Meeting on October 31, 2025, at 11:00 Indian Standard Time (Board Meeting announcement).Actualización de narrativa • Nov 17
507717: New Formulation Plant Decision Will Drive Next Wave Of Expansion
Analysts have lowered their price target for Dhanuka Agritech from ₹1,779.88 to ₹1,638.00. This reflects tempered expectations for future revenue growth and profit margins.Actualización de narrativa • Nov 03
507717: New Nagpur Plant And Higher Margins Will Drive Future Upside
Analysts have revised their price target for Dhanuka Agritech downward from ₹1,875 to ₹1,779.88. This adjustment reflects updated projections in revenue growth and profit margins, as well as a slightly reduced future valuation multiple.Actualización de narrativa • Sep 05
Improved Monsoon Trends And Capacity Expansion Will Drive Agrochemicals Demand
With both the discount rate and future P/E essentially unchanged, analysts maintained Dhanuka Agritech’s fair value at ₹1875. What's in the News Board meeting scheduled to consider and approve financial results for the quarter ended 30 June, 2025.
Nueva narrativa • Feb 09
Acquiring Rights To Iprovalicarb And Triadimenol Will Open International Markets
International expansion and product innovation could boost revenue through new market entry, geographic diversification, and premium pricing for unique solutions.Desglose de ingresos y gastos
Desglose de ingresos y gastos
Cómo gana y gasta dinero Dhanuka Agritech. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Mar 26 | 20,198 | 2,872 | 1,898 | 0 |
| 31 Dec 25 | 19,785 | 2,650 | 1,993 | 0 |
| 30 Sep 25 | 20,138 | 2,800 | 1,967 | 0 |
| 30 Jun 25 | 20,699 | 3,036 | 1,955 | 0 |
| 31 Mar 25 | 20,352 | 2,970 | 1,917 | 0 |
| 31 Dec 24 | 19,614 | 2,805 | 1,881 | 0 |
| 30 Sep 24 | 19,194 | 2,708 | 1,858 | 0 |
| 30 Jun 24 | 18,831 | 2,550 | 1,832 | 0 |
| 31 Mar 24 | 17,585 | 2,391 | 1,745 | 0 |
| 31 Dec 23 | 17,615 | 2,454 | 1,612 | 0 |
| 30 Sep 23 | 17,516 | 2,461 | 1,522 | 0 |
| 30 Jun 23 | 16,766 | 2,173 | 1,426 | 0 |
| 31 Mar 23 | 17,002 | 2,335 | 1,442 | 0 |
| 31 Dec 22 | 16,473 | 2,226 | 1,399 | 0 |
| 30 Sep 22 | 16,108 | 2,191 | 1,387 | 0 |
| 30 Jun 22 | 15,067 | 2,094 | 1,380 | 0 |
| 31 Mar 22 | 14,778 | 2,089 | 1,352 | 0 |
| 31 Dec 21 | 14,350 | 2,031 | 1,324 | 0 |
| 30 Sep 21 | 13,738 | 2,007 | 1,293 | 0 |
| 30 Jun 21 | 13,774 | 2,074 | 1,293 | 0 |
| 31 Mar 21 | 13,875 | 2,106 | 1,314 | 0 |
| 31 Dec 20 | 13,395 | 2,009 | 1,237 | 0 |
| 30 Sep 20 | 13,153 | 1,886 | 1,234 | 0 |
| 30 Jun 20 | 12,749 | 1,785 | 1,131 | 0 |
| 31 Mar 20 | 11,201 | 1,413 | 1,128 | 0 |
| 31 Dec 19 | 10,852 | 1,291 | 1,185 | 0 |
| 30 Sep 19 | 10,305 | 1,160 | 1,156 | 0 |
| 30 Jun 19 | 10,118 | 1,111 | 1,163 | 0 |
| 31 Mar 19 | 10,058 | 1,126 | 1,174 | 0 |
| 31 Dec 18 | 9,982 | 1,145 | 1,255 | 0 |
| 30 Sep 18 | 10,029 | 1,285 | 1,294 | 0 |
| 30 Jun 18 | 9,676 | 1,262 | 1,253 | 0 |
| 31 Mar 18 | 9,626 | 1,262 | 1,246 | 0 |
| 31 Dec 17 | 9,265 | 1,201 | 1,189 | 0 |
| 30 Sep 17 | 9,168 | 1,183 | 1,156 | 0 |
| 30 Jun 17 | 8,812 | 1,156 | 1,132 | 0 |
| 31 Mar 17 | 8,833 | 1,219 | 1,118 | 0 |
| 31 Dec 16 | 8,886 | 1,237 | 1,152 | 0 |
| 30 Sep 16 | 8,857 | 1,196 | 1,102 | 0 |
| 30 Jun 16 | 8,469 | 1,081 | 1,061 | 0 |
| 31 Mar 16 | 8,289 | 1,073 | 1,003 | 0 |
| 31 Dec 15 | 8,116 | 1,007 | 1,483 | 10 |
| 30 Sep 15 | 7,850 | 1,002 | 684 | 0 |
Ingresos de calidad: 507717 tiene ganancias de alta calidad.
Margen de beneficios creciente: Los actuales márgenes de beneficio(14.2%) de 507717 son inferiores a los del año pasado (14.6%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Los beneficios de 507717 han crecido un 8.2% al año en los últimos 5 años.
Acelerando crecimiento: 507717 ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.
Beneficios vs. Industria: 507717 tuvo un crecimiento negativo de los beneficios (-3.3%) durante el año pasado, lo que dificulta la comparación con la media de la industria Chemicals (13.7%).
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de 507717 (17.1%) se considera baja.
Rentabilidad económica
Rendimiento del capital invertido
Descubre empresas con buenos resultados en el pasado
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/07/09 16:21 |
| Precio de las acciones al final del día | 2026/07/09 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2026/03/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también contamos con guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Dhanuka Agritech Limited está cubierta por 17 analistas. 7 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| null null | 360 ONE Capital Market Private Limited |
| null null | Anand Rathi Shares and Stock Brokers Limited |
| Himanshu Binani | Anand Rathi Shares and Stock Brokers Limited |